Provided by Tiger Trade Technology Pte. Ltd.

Vericel

39.64
-1.3100-3.20%
Volume:117.96K
Turnover:4.71M
Market Cap:2.03B
PE:84.51
High:40.88
Open:40.48
Low:39.34
Close:40.95
52wk High:49.32
52wk Low:28.95
Shares:51.21M
Float Shares:50.46M
Volume Ratio:0.73
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4691
EPS(LYR):0.3200
ROE:7.16%
ROA:2.43%
PB:5.49
PE(LYR):123.88

Loading ...

Vericel Director Kevin F. McLaughlin Disposes of 7,000 Common Shares Worth $311,710

Reuters
·
Aug 15

Israel's MediWound Beats Q2 Revenue Estimates, Reaffirms 2026 Guidance

Reuters
·
Aug 13

Ann Arbor SPARK Hosts Ann Arbor Mobility Summit at American Center for Mobility Sept. 30

Reuters
·
Aug 12

Vericel COO Michael Halpin Disposes of USD 468,400 in Common Shares

Reuters
·
Aug 06

Vericel Principal Accounting Officer Jonathan Siegal Disposes of 4,500 Common Shares Worth $220,050

Reuters
·
Aug 01

Vericel Price Target Raised to $58.00/Share from $54.00 by Truist Securities

Dow Jones
·
Jul 31

Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating

MT Newswires Live
·
Jul 31

Vericel Corp : Leerink Partners Raises Target Price to $59.00 from $46.00

THOMSON REUTERS
·
Jul 31

Vericel Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Vericel Swings to Q2 Net Income, Revenue Rises; Full-Year 2026 Revenue Guidance Raised

MT Newswires Live
·
Jul 30

Vericel Beats Q2 Revenue Estimates, Boosts Annual Outlook

Reuters
·
Jul 30

GUIDANCE: (VCEL) Vericel Expects Full Year 2026 Revenue Range $330M - $340M, vs. FactSet Est of $332.2M

MT Newswires Live
·
Jul 30

Earnings Flash (VCEL) Vericel Posts Q2 EPS $0.04, vs. FactSet Est. of $0.03 Loss

MT Newswires Live
·
Jul 30

Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate

Benzinga Earnings
·
Jul 30

Vericel Q2 EPS USD 0.04

Reuters
·
Jul 30

Vericel Outlook FY Revenue USD 330-340 Million

THOMSON REUTERS
·
Jul 30

Vericel Corp - Authorizes $200 Mln Share Repurchase Program

THOMSON REUTERS
·
Jul 30

Vericel Q2 Gross Margin 73%

THOMSON REUTERS
·
Jul 30

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

THOMSON REUTERS
·
Jul 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)

TIPRANKS
·
Jul 28